Protein inhibitors market to reach $148.83 billion by 2030 at 9.0% CAGR, driven by rising demand for personalized medicine.
Read More
Protein hydrolysis enzymes market to reach $3.2 billion by 2030 at 6.3% CAGR, driven by increasing prevalence of chronic diseases.
Read More
Protein degradation therapy market to reach $1.83 billion by 2030 at 7.8% CAGR, driven by growing burden of cancer.
Read More
Proteasome inhibitors market to reach $3.49 billion by 2030 at 10.2% CAGR, driven by increasing prevalence of pancreatic cancer.
Read More
Prostate cancer therapeutics market to reach $19.25 billion by 2030 at 8.4% CAGR, driven by increasing incidence of prostate cancer.
Read More
Prostate cancer drugs market to reach $26.15 billion by 2030 at 6.2% CAGR, driven by increasing men geriatric population.
Read More
Propranolol drug market to reach $1.41 billion by 2030 at 5.2% CAGR, driven by growing prevalence of cardiovascular diseases.
Read More
Programmed death (PD)-1 non-small cell lung cancer market to reach $41.45 billion by 2030 at 8.5% CAGR, driven by increasing adoption of personalized treatments.
Read More
Progesterone market to reach $3.54 billion by 2030 at 14.5% CAGR, driven by increasing prevalence of hormonal disorders.
Read More
Process analytical technology market to reach $5.4 billion by 2030 at 9.8% CAGR, driven by rising demand for personalized medicine.
Read More